Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence

Mult Scler. 2012 Dec;18(12):1801-3. doi: 10.1177/1352458512443994. Epub 2012 Apr 11.

Abstract

In a recent study, administration of granulocyte colony stimulating factor (G-CSF) increased neuromyelitis optica (NMO) lesions in mice. Here we report a patient whose first episode of NMO may have been exacerbated by inadvertent administration of G-CSF. Histological examination of brain and spinal cord samples from three other NMO patients revealed markedly increased expression of G-CSF in neurons located in and around the lesions, with little or no expression in multiple sclerosis lesions or normal white matter. Taken together, these cases support a detrimental role for G-CSF in NMO pathogenesis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Granulocyte Colony-Stimulating Factor / analysis
  • Granulocyte Colony-Stimulating Factor / metabolism
  • Humans
  • Male
  • Medication Errors / adverse effects*
  • Neuromyelitis Optica / metabolism*
  • Neuromyelitis Optica / pathology
  • Recombinant Proteins / adverse effects

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim